Skip to main content
. 2022 Aug 2;45(10):995–1001. doi: 10.1002/clc.23889

Figure 2.

Figure 2

Effects of tolvaptan on patient‐assessed dyspnea at (A) 8, (B) 12, (C) 24 h or day 1, (D) 48, and (E) 72 h. CI, confidence interval, M−H, Mantel−Haenszel.